Kevin contributes to various projects for a diverse group of clients. Kevin has extensive experience in actuarial, finance, and strategic projects, providing market intelligence and strategy support for clients across the healthcare industry. Kevin is also passionate about helping clients navigate, digest, and strategize for health policy changes.
Kevin possesses deep expertise in the pharmacy industry to support various stakeholders, including health plans, pharmacy benefit managers (PBMs), drug manufacturers, patient advocacy groups, and specialty hubs. Kevin has experience in leading product, underwriting, and point solution reviews for pharmacy clients, with a strong understanding of solutions and capabilities offered by key competitors in the market. In addition, Kevin’s pharmacy experience extends to more financially focused activities, such as financial analysis, competitive benchmarking, and forecasting, to name a few.
Kevin is a thought leader in the Medicare Advantage market, with a concentration in Medicare Part D. Kevin leads the Part D bid development for both standalone Prescription Drug Plans (PDPs) and Medicare Advantage Prescription Drug (MAPD) plans. Kevin provides strategic support to help clients evaluate health policy changes, forecast Part D low-income benchmarks and national averages, assess new demonstration programs and highlight competitive trends. In addition, Kevin supports CMS bid audits and develops feasibility studies for new market entrants in the Medicare Advantage market. Kevin’s experience extends to the group Part D market, including Employer Group Waiver Plan (EGWP) pricing and strategy for employers and PBMs.
Kevin also has substantial experience with financial statements, risk-based capital (RBC), mergers and acquisitions, and other related healthcare finance topics.
